Offer - Urjas Oil for just ₹ 1 X
Albrim Lst is a prescription medicine that is available as a Drops. Albrim Lst also has some secondary and off-label uses. These are listed below.
The right dosage of Albrim Lst depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Albrim Lst also has some side effects, the most common being Eye Burning, Eye irritation, Stinging in the Eyes. While these are the most often observed Albrim Lst side effects, there are can be others also. These have been listed below. These side effects of Albrim Lst are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Albrim Lst's effect during pregnancy is Mild and Unknown while nursing. Warnings related to Albrim Lst's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Albrim Lst since this can cause severe adverse effects. Other conditions have been mentioned below in the Albrim Lst contraindications section.
Drug interactions for Albrim Lst have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Albrim Lst, it is important to know that it is safe while driving, and is habit-forming.
Albrim Lst is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Albrim Lst safe for pregnant women?
Albrim LST rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Albrim Lst safe during breastfeeding?
In the absence of any scientific study about the side effects of Albrim LST in breastfeeding women, information on safety of Albrim LST is unavailable.
What is the effect of Albrim Lst on the Kidneys?
There can be some harmful effects on your kidneys after taking Albrim LST. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Albrim Lst on the Liver?
The liver can be affected by Albrim LST. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Albrim LST only after medical advice.
What is the effect of Albrim Lst on the Heart?
Albrim LST may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Albrim Lst should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Albrim Lst unless your doctor advises you to do so -
Is this Albrim Lst habit forming or addictive?
Albrim Lst is not addictive in nature.
Interaction between Food and Albrim Lst
You can take Albrim Lst with food.
Interaction between Alcohol and Albrim Lst
Information about the interaction of Albrim Lst and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)